Back to Search Start Over

Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2

Authors :
Craig Anderson
Raf Brouns
Joseph Kwan
David Werring
John Chalmers
Emma Heeley
Angel Chamorro
Graeme Hankey
Pablo Lavados
Dominique Hervé
Serge Timsit
Qiang Li
Richard Lindley
Francesco Corea
Tiago Gregorio
Daniel Strbian
Filip Scheperjans
Emmanuel Touzé
Sylvie De Raedt
Mark Woodward
Andrea Zini
Thomas W Leung
Xia Wang
Sami Curtze
David Blacker
Ann De Smedt
C.J.M. Klijn
María del Mar Castellanos
Charlotte Cordonnier
Thompson Robinson
Markku Kaste
Danilo Toni
Laurent Billot
Candice Delcourt
Christian Stapf
Tissa Wijeratne
Victoria Haunton
Supporting clinical sciences
UZB Other
Physical Medicine and Rehabilitation
Clinical sciences
Neuroprotection & Neuromodulation
Neurology
Vriendenkring VUB
Department of Earth Sciences [Uppsala]
Uppsala University
Laboratoire de Glaciologie
Département des Sciences de la Terre et de l'Environnement
CAN-FOR
National Institute of Advanced Science and Technology
Génétique, génomique fonctionnelle et biotechnologies (UMR 1078) (GGB)
Institut Brestois Santé Agro Matière (IBSAM)
Université de Brest (UBO)-Université de Brest (UBO)-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM)
CIC Brest
Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital de la Cavale Blanche
Source :
Neurology, 84, 5, pp. 464-71, Neurology, 84, 464-71, ResearcherID, Neurology, Neurology, American Academy of Neurology, 2015, 84 (5), pp.464-471. ⟨10.1212/WNL.0000000000001205⟩
Publication Year :
2014
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2014.

Abstract

Item does not contain fulltext OBJECTIVES: To investigate the effects of intensive blood pressure (BP) lowering according to baseline BP levels and optimal achieved BP levels in patients with acute intracerebral hemorrhage (ICH). METHODS: INTERACT2 was an open, blinded endpoint, randomized controlled trial in 2,839 patients with ICH within 6 hours of onset and elevated systolic BP (SBP) (150-220 mm Hg) who were allocated to receive intensive (target SBP /=190 mm Hg (p homogeneity = 0.790). Analyses of achieved BP showed linear increases in the risk of physical dysfunction for achieved SBP above 130 mm Hg for both hyperacute (1-24 hours) and acute (2-7 days) phases while modest increases were also observed for achieved SBP below 130 mm Hg. CONCLUSIONS: Intensive BP lowering appears beneficial across a wide range of baseline SBP levels, and target SBP level of 130-139 mm Hg is likely to provide maximum benefit in acute ICH. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that the effect of intensive BP lowering on physical function is not influenced by baseline BP.

Details

ISSN :
1526632X and 00283878
Volume :
84
Database :
OpenAIRE
Journal :
Neurology
Accession number :
edsair.doi.dedup.....7150df83ee95a627082165e19cb8de27
Full Text :
https://doi.org/10.1212/wnl.0000000000001205